Union City, CA, United States of America

Zhiqing Zhang

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Novodiax, Inc.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhiqing Zhang. Retrieved from https://idiyas.com/inventor/zhiqing-zhang-e5n2nsta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zhiqing Zhang: Innovator in Immunohistochemistry

Introduction

Zhiqing Zhang is a notable inventor based in Union City, CA (US). He has made significant contributions to the field of immunohistochemistry, particularly through his innovative patent.

Latest Patents

Zhiqing Zhang holds a patent for a Direct Immunohistochemistry Assay. This application involves antibodies that have been labeled with polyenzymes, specifically polyperoxidases, for use in direct immunohistochemical assays of tissues. The antibodies utilized in this diagnostic method may also serve therapeutic purposes.

Career Highlights

Zhiqing Zhang is currently employed at Novodiax, Inc., where he continues to advance his research and development in immunohistochemistry. His work has the potential to enhance diagnostic and therapeutic applications in medical science.

Collaborations

Zhiqing has collaborated with notable colleagues, including Song Qing Zhao and Jianfu Jeffrey Wang, contributing to a dynamic research environment.

Conclusion

Zhiqing Zhang's innovative work in immunohistochemistry exemplifies the impact of scientific research on healthcare. His contributions are paving the way for advancements in diagnostic and therapeutic methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…